Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders
Drug and Alcohol Dependence Reports · 2025-06 · 15 · 100328
DOI: 10.1016/j.dadr.2025.100328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Dependence Reports, 2025-06. Verfasst von Rebecca Fish und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Research, Lancaster University, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Long-acting injectable buprenorphine (LAIB) is a relatively novel pharmacological treatment for people with opioid dependence. Despite growing qualitative evidence, there is limited research on practitioner insights, and effectiveness of LAIB in a community setting.
Methods
Thirteen service-users (11 currently prescribed LAIB), 6 practitioners, and 4 stakeholders (public health workers) took part in semi-structured interviews (n = 23) to glean their perspectives on LAIB. They were recruited through a community drug treatment service in the NW of England. The interview schedule was informed by previous literature and co-produced with a peer worker with lived experience of drug recovery treatment. Transcripts were analysed thematically by the research team.
Results
Four major themes were identified from the interviews: A change of focus; challenges; wrap-around support; and target groups.
Discussion
Our findings support existing evidence around the individual benefits to service-users such as changes to lifestyle and reduction of stigma, as well as challenges such as the need for wrap-around support and accessible information. We found that commissioning considerations such as geographical inequalities and the need for multi-service collaboration are important in this setting.
Conclusions
LAIB treatment works well for many people in a community context that offers significant wrap-around support to service-users. The novelty of this research lies in bringing together the views of practitioners and stakeholders as well as treatment/service beneficiaries in evaluating the introduction of LAIB in a community service.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Health Research, Lancaster University, UK.
- Lancaster Medical School, Lancaster University, UK.
Zitieren
APA
Fish, R., Mateus, C., Maiden, H., Lawson, E., & Limmer, M. (2025). Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders. Drug and Alcohol Dependence Reports, 15, 100328. https://doi.org/10.1016/j.dadr.2025.100328
Vancouver
Fish R, Mateus C, Maiden H, Lawson E, Limmer M. Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders. Drug and Alcohol Dependence Reports. 2025;15:100328. doi:10.1016/j.dadr.2025.100328
BibTeX
@article{Fish2025,
author = {Fish, Rebecca and Mateus, Céu and Maiden, Hannah and Lawson, Euan and Limmer, Mark},
title = {Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders},
journal = {Drug and Alcohol Dependence Reports},
year = {2025},
volume = {15},
pages = {100328},
doi = {10.1016/j.dadr.2025.100328}
}
EUVIMED